Atlas Trials

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Clinical trial NCT02910752 · SUSPENDED

Trial details

NCT number
NCT02910752
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2016-09-01
Primary completion
2023-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.